Last updated: May 6, 2024
Sponsor: Huazhong University of Science and Technology
Overall Status: Active - Recruiting
Phase
N/A
Condition
Genitourinary Cancer
Stomach Cancer
Digestive System Neoplasms
Treatment
pCLE-gastr
Clinical Study ID
NCT06389448
pCLE vs EB 2024tj
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Over 18 years old and under 75 years old;
- Patients with pathological diagnosis of LGIN, HGIN or early gastric cancer afterconventional endoscopy biopsy, whose lesion has clear boundaries under endoscopicobservation and is to be admitted for ESD surgery;
- Patients who meet the indications for endoscopic resection of early gastric cancer, orLGIN patients who intend to undergo ESD surgery;
- Patients who are able to provide pathological specimens/sections of previousendoscopic biopsy (in principle, it should be a case of this center).
Exclusion
Exclusion Criteria:
- Patients with advanced gastric cancer or previous gastrectomy;
- Patients with severe cardiopulmonary dysfunction, liver cirrhosis, renal dysfunction,acute gastrointestinal bleeding, esophageal-gastro varices, and coagulation disorders;
- Patients who have a positive result in the fluorescein sodium allergy test;
- Pregnant and lactating women;
- Patients who have psychiatric disorders and are unable to cooperate with endoscopy orsign informed consent.
Study Design
Total Participants: 366
Treatment Group(s): 1
Primary Treatment: pCLE-gastr
Phase:
Study Start date:
April 11, 2024
Estimated Completion Date:
October 31, 2026
Study Description
Connect with a study center
Tongji hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei 430030
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.